Tassos Gianakakos
2016
In 2016, Tassos Gianakakos earned a total compensation of $1.1M as President, Chief Executive Officer and Director at MyoKardia, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,600 |
|---|---|
| Option Awards | $424,306 |
| Salary | $459,545 |
| Other | $500 |
| Total | $1,104,951 |
Gianakakos received $459.5K in salary, accounting for 42% of the total pay in 2016.
Gianakakos also received $220.6K in non-equity incentive plan, $424.3K in option awards and $500 in other compensation.
Rankings
In 2016, Tassos Gianakakos' compensation ranked 7,750th out of 14,075 executives tracked by ExecPay. In other words, Gianakakos earned more than 44.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,750 out of 14,075 | 45th |
Division Manufacturing | 2,943 out of 5,489 | 46th |
Major group Chemicals And Allied Products | 973 out of 1,895 | 49th |
Industry group Drugs | 755 out of 1,538 | 51st |
Industry Pharmaceutical Preparations | 601 out of 1,176 | 49th |
Source: SEC filing on April 25, 2017.
Gianakakos' colleagues
We found two more compensation records of executives who worked with Tassos Gianakakos at MyoKardia in 2016.